Department of Respiratory Failure
2014年11月1日掲載
Introduction

Director, Toru ARAI
Ongoing project
* Physiological aspects of interstitial lung diseases (ILDs) and autoimmune pulmonary alveolar proteinosis (APAP)
* Predictive factors and prognostic factors of acute exacerbation in IIPs
* Single Arm Open Labeled Multicenter Trial for Safety and Efficacy of recombinant human soluble Thrombomodulin for Acute Exacerbation of Idiopathic Interstitial Pneumonias (SETUP Trial)
* Lower lobe predominance sarcoidosis
* Standardization of whole lung lavage for APAP
* Importance of emphysema complicated with Interstitial pneumonia
* Gene polymorphism in ILDs and APAP
* Rehabilitation of APAP before and after whole lung lavage
* Compliance of continuous positive airway pressure in sleep apnea syndrome
* Registration of COPD
* Predictive factors and prognostic factors of acute exacerbation in IIPs
* Single Arm Open Labeled Multicenter Trial for Safety and Efficacy of recombinant human soluble Thrombomodulin for Acute Exacerbation of Idiopathic Interstitial Pneumonias (SETUP Trial)
* Lower lobe predominance sarcoidosis
* Standardization of whole lung lavage for APAP
* Importance of emphysema complicated with Interstitial pneumonia
* Gene polymorphism in ILDs and APAP
* Rehabilitation of APAP before and after whole lung lavage
* Compliance of continuous positive airway pressure in sleep apnea syndrome
* Registration of COPD